Study: Monkeys Develop Virus Immunity After Infection, Vaccine
Two studies on monkeys published on Wednesday offer hope that humans can develop protective immunity to the novel coronavirus.
The studies, published in the journal Science, looked at a prototype vaccine and whether infection with SARS-CoV-2 provides immunity against re-exposure.
Both questions are critical as researchers tackle the virus, which has infected nearly five million people around the world and caused more than 325,000 deaths.
The studies were carried out on rhesus macaque monkeys to see whether they develop protective virus immunity from natural infection or from a vaccine.
“The global COVID-19 pandemic has made the development of a vaccine a top biomedical priority, but very little is currently known about protective immunity to the SARS-CoV-2 virus,” said senior author Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston.
“In these two studies, we demonstrate in rhesus macaques that prototype vaccines protected against SARS-CoV-2 infection and that SARS-CoV-2 infection protected against re-exposure,” Barouch said.
In one study carried out
The monkeys developed COVID-19 symptoms but created protective antibodies and recovered after a few days.
To test their immunity, they were exposed to SARS-CoV-2 again 35 days later for what is called a “re-challenge”, and they showed few to no symptoms.
The authors of the study cautioned that further research will be needed because of the “important differences” between SARS-CoV-2 infection in monkeys and humans.
“Rigorous clinical studies will be required to determine whether SARS-CoV-2 infection effectively protects against SARS-CoV-2 re-exposure in humans,” they said.
The second study, involving many of the same researchers and led by Jingyou Yu, involved vaccinating 35 adult macaques with DNA vaccine candidates designed to generate protective antibodies.
They were exposed to the coronavirus six weeks later and had developed levels of antibodies in the blood sufficient to neutralize it, the study found.
The levels of antibodies, it said, were similar to those seen in humans recovering from the virus, providing hope that an effective human vaccine can be developed.
“Further research will need to address the important questions of the durability of protective immunity and the optimal vaccine platforms for a SARS-CoV-2 vaccine for humans,” the authors of the study said.
AFP
About author
You might also like
FG Selects Federal Poly Nekede For Broadband Internet Development
The Federal Government has selected the Federal Polytechnic Nekede for broadband internet development. This development comes on the heels of a most robust smart campus project prosecuted by the frontline
Buhari Charges Police to be professional
President Muhammadu Buhari has charge the police to be more professional in all their operations and shun unprofessional acts such as illegal detention, extrajudicial killings, torture and violation of fundamental
Black Wednesday: Scores of Lives, Properties Lost as Fire Engulf Ochanja Market, Onitsha (Photos & Videos)
Francis Emekwe, Chisom Ajoku and ThankGod Emeh Residents and Traders at Ochanja market, Upper Iweka road, Onitsha, Anambra State and environs on Wednesday, October 16, 2019 witnessed black moment as
George Floyd: Pelosi Seeks Removal of Confederate Statues From Capitol
House Speaker Nancy Pelosi called Wednesday for removal of 11 Confederate statues from the US Capitol, part of a nationwide push to dismantle such memorials after a black man’s killing
Okey Ezeh charge Imo Stakeholders to support, vote Competence & Credibility.
The governorship candidate of the Social Democratic Party, SDP, in Imo State, Sir Okey Ezeh has called on all opinion leaders, the mass media, civil society groups, cultural unions, faith-based
Trump declares North Korea ‘no longer a nuclear threat
President Donald Trump declared Wednesday that the North Korean regime no longer poses a nuclear threat following his summit with Kim Jong Un, even though the meeting produced no verifiable
0 Comments
No Comments Yet!
You can be first to comment this post!